Clinical Trials Logo

Clinical Trial Summary

Rhizarthrosis (trapeziometacarpal osteoarthritis) is the most common primary osteoarthritis of the hand, and a source of major functional impact, as it affects the thumb. Non-surgical therapeutic means are currently limited to wearing an immobilization splint, analgesics and oral non-steroidal anti-inflammatory drugs. These symptomatic treatments are of limited effectiveness and do not prevent from progression of the osteoarthritis disease. The most effective treatments currently recognized are surgical, but they also have their limits. Cell therapy is considered as a promising approach to treat tissue damage including osteoarthritis. Mesenchymal stromal cells are excellent candidates for achieving this type of result, because they can differentiate into the different tissues from the mesoderm (cartilage, bone, muscle, tendons, fat, dermis, conjunctive matrix, etc.). In addition, unlike cells from the embryonic cord, the risk of teratoma or tumor does not exist. Mesenchymal stem cells have regenerative and immunomodulatory properties but the methods of collection, preparation, combination with substances such as hyaluronic acid, or PRP, or platelet concentrates, will obviously influence the effectiveness of the results. . Nanofat autografts are obtained in a simple way, in a closed circuit, preserving the stromal mesenchymal cells in large numbers with a minimum impact on the cellular elements. The preparation remains simple and inexpensive, but it is nevertheless necessary to characterize these emulsified preparations biologically before using them as cell therapy. The main objective of this study is to characterize a nanofat autograft on a biological level.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05915962
Study type Interventional
Source Ramsay Générale de Santé
Contact
Status Completed
Phase N/A
Start date June 3, 2022
Completion date September 9, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04829565 - Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb Phase 4
Recruiting NCT05047744 - Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis N/A
Active, not recruiting NCT04115085 - Study of Medical Ultrasound for Rhizarthrosis N/A
Recruiting NCT06078189 - Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy
Completed NCT03320291 - Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis N/A
Completed NCT04587570 - Rhizarthrosis Study N/A
Completed NCT02676284 - Durolane SJ for Treatment of Rhizarthrosis N/A
Recruiting NCT05597930 - New 3D Printed Wrist Orthosis N/A
Completed NCT03431584 - Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis. Phase 4
Active, not recruiting NCT03089723 - Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis N/A
Recruiting NCT01233739 - Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis. Phase 4
Not yet recruiting NCT04588961 - Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis N/A
Terminated NCT03020368 - Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint N/A
Completed NCT05169099 - Post-operative Results of the Trapezometacarpal (TMC) Prosthesis for Advanced Pre-operative Deformities
Recruiting NCT03879434 - Routine Application of Ostenil® Mini in Patients With Rhizarthrosis
Not yet recruiting NCT05708430 - Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis Phase 2